Your session is about to expire
← Back to Search
Device
Wearable Breast Pump for Low Milk Supply
N/A
Waitlist Available
Led By Leslie Parker
Research Sponsored by University of Florida
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
> 18 years of age
Access to a mobile phone and able to download app.
Must not have
Breast reduction or augmentation
Positive HIV status
Timeline
Screening 3 weeks
Treatment Varies
Follow Up at 20-22 days
Awards & highlights
No Placebo-Only Group
Summary
This trial aims to help Black mothers of critically ill infants in the NICU by providing a wearable breast pump that can be used hands-free. The pump comes with an app that tracks how often they pump and how much milk they produce. This could make it easier for these mothers to provide more breast milk for their babies.
Who is the study for?
This trial is for Black mothers over 18 with critically ill infants in the NICU who intend to pump breast milk and can attend a training session. They must have a mobile phone, be English-speaking, and not expect their infant to bottle/breastfeed within 21 days. Exclusions include drug use, breast surgery history, HIV positivity, pacemaker presence or if the infant's life expectancy is under 7 days.
What is being tested?
The study tests whether a discreet hands-free wearable breast pump increases lactation success compared to standard pumps without an app. It aims to improve pumping frequency and milk production among Black mothers of NICU infants by using technology that tracks these metrics.
What are the potential side effects?
While there are no direct medical side effects from using a breast pump, potential issues may include discomfort during use, nipple irritation or soreness, and possible stress related to adapting to new technology.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am older than 18 years.
Select...
I have a mobile phone and can download apps.
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
I have had breast surgery to change size.
Select...
I am HIV positive.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ at 20-22 days
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~at 20-22 days
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Number of participants acceptance of the intervention
Secondary study objectives
Expressed milk volume
Expression frequency
Infant consumption
+2 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Intervention GroupExperimental Treatment1 Intervention
Will be provided a discreet, hands-free, wearable breast pump with an associated App
Group II: Standard care groupActive Control1 Intervention
Will be provided a standard mechanical breast pump with no associated App.
Research Highlights
Information in this section is not a recommendation. We encourage patients to speak with their healthcare team when evaluating any treatment decision.Mechanism Of Action
Side Effect Profile
Prior Approvals
Other Research
Common treatments for low milk supply include frequent breast pumping, use of breast pumps that mimic the baby's sucking pattern, and tracking milk production. The discreet, hands-free, wearable breast pump with an associated app increases pumping frequency and provides real-time data on milk production.
This matters for patients with low milk supply because frequent stimulation of the breasts can enhance milk production by promoting the release of prolactin and oxytocin, hormones essential for milk synthesis and ejection. Additionally, tracking milk production helps in identifying patterns and making necessary adjustments to improve lactation success.
Find a Location
Who is running the clinical trial?
University of FloridaLead Sponsor
1,404 Previous Clinical Trials
766,290 Total Patients Enrolled
Leslie ParkerPrincipal InvestigatorUniversity of Florida
2 Previous Clinical Trials
301 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am older than 18 years.The baby is not expected to live more than 7 days after being born.You have a history of using illegal drugs.I can attend a 30-minute education session before leaving the hospital.I have a mobile phone and can download apps.I have had breast surgery to change size.I am HIV positive.You have a pacemaker implanted.You plan to breastfeed your baby.I am committed to pumping breast milk for at least 3 weeks.The participant's mother identifies as Black.
Research Study Groups:
This trial has the following groups:- Group 1: Intervention Group
- Group 2: Standard care group
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.